As medical professionals, we continually strive to understand the intricacies of diseases that affect the human body. One such condition is Parkinson's disease (PD), a neurodegenerative disorder with a multifaceted etiology and presentation.
PD is primarily characterized by the degeneration of dopaminergic neurons in the substantia nigra pars compacta. This loss leads to decreased striatal dopamine levels, disrupting the balance between the direct and indirect pathways of the basal ganglia, resulting in motor symptoms.
The cardinal symptoms of PD include bradykinesia, resting tremor, rigidity, and postural instability. However, non-motor symptoms such as autonomic dysfunction, cognitive impairment, and mood disorders are also prevalent and significantly impact patients' quality of life.
PD diagnosis is primarily clinical, based on the presence of characteristic motor symptoms. Neuroimaging techniques like DAT-SPECT can support the diagnosis but are not routinely used due to their high cost and limited availability. There are no specific biomarkers for PD, making early diagnosis challenging.
Treatment of PD is symptomatic, with levodopa being the most effective medication for motor symptoms. However, its long-term use is associated with motor complications. Other treatment options include dopamine agonists, MAO-B inhibitors, and deep brain stimulation for refractory cases.
Current research efforts are focused on understanding the genetic and environmental factors contributing to PD's pathogenesis, identifying reliable biomarkers for early diagnosis, and developing disease-modifying therapies.
PD is a complex disorder with a significant impact on patients' lives. As medical professionals, we must stay abreast of the latest research to provide the best care for our patients and contribute to the ongoing efforts to unravel the mysteries of this disease.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation